Maharashtra FDA Demands Price Control for Medical Devices
The story in brief
Maharashtra FDA flagged price disparities in medical devices, citing a market survey showing significant gaps between procurement costs and MRPs. Hospitalised patients in Maharashtra have limited ability to compare prices or negotiate costs for essential medical devices, raising concerns over transparency and accountability. The FDA requested the Centre to examine the issue and consider price regulation for essential devices.